During the past decade, Kyiv City Clinical Oncological Center conducted 39 clinical trials. In the 10-year time frame, 39 clinical trials started and 13 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 25 clinical trials started and 8 clinical trials were completed. i.e. 32% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kyiv City Clinical Oncological Center" #1 sponsor was "Hoffmann-La Roche" with 13 trials, followed by "Janssen Research & Development, LLC" with 5 trials sponsored, "Merck Sharp & Dohme LLC" with 4 trials sponsored, "Incyte Corporation" with 3 trials sponsored and "BeyondSpring Pharmaceuticals Inc." with 3 trials sponsored. Other sponsors include 18 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kyiv City Clinical Oncological Center" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Merck Sharp & Dohme LLC" with 2 trials as a collaborator, "Astellas Pharma Global Development, Inc." with 1 trials as a collaborator, "BeiGene, Ltd." with 1 trials as a collaborator and "Chiltern International Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Kyiv City Clinical Oncological Center" are "Carcinoma, Non-Small-Cell Lung" (4 trials), "Non-Small Cell Lung Cancer" (4 trials), "Breast Cancer" (2 trials), "Breast Neoplasms" (2 trials) and "COVID-19" (2 trials). Many other conditions were trialed in "Kyiv City Clinical Oncological Center" in a lesser frequency.

Most popular intervention types in "Kyiv City Clinical Oncological Center" are "Drug" (44 trials), "Biological" (6 trials), "Other" (5 trials), "Device" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (18 trials), "Cisplatin" (9 trials), "Pembrolizumab" (7 trials), "Carboplatin" (6 trials) and "Paclitaxel" (6 trials). Other intervention names were less common.

The vast majority of trials in "Kyiv City Clinical Oncological Center" are 43 trials for "All" genders, 4 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Kyiv City Clinical Oncological Center". undefined are not yet recruiting, 13 are recruiting, 13 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Kyiv City Clinical Oncological Center, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Kyiv City Clinical Oncological Center, 4 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 36 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Kyiv City Clinical Oncological Center has several departments that took part in Clinical trials: "Cnce 'Kyiv City Psychoneurological Hospital #2' of Executive Body of Kyiv City Council (Kcsa)" - 18 trials, "Kyiv Regional Oncological Dispensary" - 8 trials, "Communal institution of the Kyiv Regional Council "Kyiv Regional Clinical Oncology Dispensary"" - 8 trials, "Clinical Diagnostic Center - Pediatric Cardiovascular and ANES and Intensive Care Department - Site 4103" - 2 trials